» Articles » PMID: 20582167

Metallomic Profiling and Linkage Map Analysis of Early Parkinson's Disease: a New Insight to Aluminum Marker for the Possible Diagnosis

Overview
Journal PLoS One
Date 2010 Jun 29
PMID 20582167
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Parkinson's disease (PD) is the most common neurodegenerative disorder. The diagnosis of PD is challenging and currently none of the biochemical tests have proven to help in diagnosis. Serum metallomic analysis may suggest the possibility of diagnosis of PD.

Methodology/results: The metallomic analysis was targeted on 31 elements obtained from 42 healthy controls and 45 drug naive PD patients using ICP-AES and ICP-MS to determine the concentration variations of elements between PD and normal. The targeted metallomic analysis showed the significant variations in 19 elements of patients compared to healthy control (p<0.04). The partial least squares discriminant analysis (PLS-DA) showed aluminium, copper, iron, manganese and zinc are the key elements, contributes the separation of PD patients from control samples. The correlation coefficient analysis and element-element ratio confirm the imbalance of inter-elements relationship in PD patients' serum. Furthermore, elements linkage map analysis showed aluminium is a key element involved in triggering of phosphorus, which subsequently lead to imbalance of homeostatic in PD serum. The execution of neural network using elements concentrations provides 95% accuracy in detection of disease.

Conclusions/significance: These results suggest that there is a disturbance in the elements homeostasis and inter-elements relationship in PD patients' serum. The analysis of serum elements helps in linking the underlying cellular processes such as oxidative stress, neuronal dysfunction and apoptosis, which are the dominating factors in PD. Also, these results increase the prospect of detection of early PD from serum through neural network algorithm.

Citing Articles

Association between Parkinson disease and selenium levels in the body: A systematic review and meta-analysis.

Chen Q, Hu X, Zhang T, Ruan Q, Wu H Medicine (Baltimore). 2024; 103(17):e37919.

PMID: 38669409 PMC: 11049729. DOI: 10.1097/MD.0000000000037919.


Changes in Bacterial Gut Composition in Parkinson's Disease and Their Metabolic Contribution to Disease Development: A Gut Community Reconstruction Approach.

Forero-Rodriguez J, Zimmermann J, Taubenheim J, Arias-Rodriguez N, Caicedo-Narvaez J, Best L Microorganisms. 2024; 12(2).

PMID: 38399728 PMC: 10893096. DOI: 10.3390/microorganisms12020325.


An Update Overview on Mechanistic Data and Biomarker Levels in Cobalt and Chromium-Induced Neurodegenerative Diseases.

Ajibo D, Orish C, Ruggieri F, Bocca B, Battistini B, Frazzoli C Biol Trace Elem Res. 2023; 202(8):3538-3564.

PMID: 38017235 DOI: 10.1007/s12011-023-03965-w.


Bioinorganic Chemistry of Micronutrients Related to Alzheimer's and Parkinson's Diseases.

Kola A, Nencioni F, Valensin D Molecules. 2023; 28(14).

PMID: 37513339 PMC: 10385134. DOI: 10.3390/molecules28145467.


Aluminium in the Human Brain: Routes of Penetration, Toxicity, and Resulting Complications.

Brylinski L, Kostelecka K, Wolinski F, Duda P, Gora J, Granat M Int J Mol Sci. 2023; 24(8).

PMID: 37108392 PMC: 10139039. DOI: 10.3390/ijms24087228.


References
1.
Vasudevaraju P, Govindaraju M, Palanisamy A, Sambamurti K, Rao K . Molecular toxicity of aluminium in relation to neurodegeneration. Indian J Med Res. 2008; 128(4):545-56. View

2.
Carri M, Ferri A, Cozzolino M, Calabrese L, Rotilio G . Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull. 2003; 61(4):365-74. DOI: 10.1016/s0361-9230(03)00179-5. View

3.
Savory J, Herman M, Ghribi O . Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain. J Inorg Biochem. 2003; 97(1):151-4. DOI: 10.1016/s0162-0134(03)00258-7. View

4.
Gibb W, Lees A . The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988; 51(6):745-52. PMC: 1033142. DOI: 10.1136/jnnp.51.6.745. View

5.
Huang X, Cuajungco M, Atwood C, Hartshorn M, Tyndall J, Hanson G . Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem. 1999; 274(52):37111-6. DOI: 10.1074/jbc.274.52.37111. View